If you have a patient who is 60 years or older, we want to hear from you.
This research study is aimed to help us understand the relationship of blood amyloid-beta to amyloid-beta deposits in the brain. Amyloid-beta deposits in the brain are a key part of diagnosis of Alzheimer’s disease (AD), which is the most common cause of dementia. The purpose of this research study is to further develop and validate a blood test for AD. This test is still in development and has not been approved by the U.S. Food and Drug Administration.
As a physician or other health professional, you can participate in this effort by referring patients to us.
Contact us to learn more .
